When you flip a light switch you expect the room to brighten. You do not think about miles of wiring or the transformers humming underground. Private credit is that invisible infrastructure for the modern economy. It underwrites buyouts, funds healthcare rollups, and backs software companies. It is a $3 trillion ecosystem operating outside traditional bank regulation. Right now the structure is showing stress fractures that matter to investors, pensioners, and patients.

1.Quick summary - what’s happening right now

  • Private credit ballooned after 2008 as banks were forced to deleverage and yield-starved institutions chased higher returns.
  • Most loans are floating-rate. Rising interest rates have pushed borrower interest bills far higher than when the loans were underwritten.
  • Funds use legal quarantines (SPV silos) to isolate losses. That protection is being eroded by fund-level NAV loans and accounting fixes like PIK.
  • Banks are marking down collateral tied to legacy SaaS companies because AI threatens future cash flows - that reduces borrowing capacity for funds.
  • Retail "evergreen" funds promise liquidity they cannot easily deliver if redemptions spike. Funds are gating withdrawals already.
  • Healthcare roll-ups financed with private credit show the weakest coverage ratios and the most direct real-world harm when debt fails.

2.How the private credit machine was built

After the 2008 crisis, regulators tightened bank capital rules. Traditional lenders pulled back. Pension funds, insurers, and other institutions could not achieve target returns on low-yield government bonds. Private credit filled that gap by offering 8 to 10 percent yields and funding leveraged buyouts (LBOs).

Mechanics in brief:

  1. Private equity buys a company using lots of debt - 60 to 90 percent leverage in classic LBOs.
  2. The buyer puts that debt into a Special Purpose Vehicle (SPV) - a separate legal entity - so losses from one deal can't be used to offset other investments.
  3. Investors receive money through dividends or selling assets. Fund managers are assessed based on Distributed to Paid-In Capital (DPI), which is how much cash is returned to limited partners.

3.Why floating rates are the stress test

Most private credit loans are floating-rate. When the Federal Reserve raised rates to fight inflation, those loans re-priced. That is not a problem in isolation - higher rates increase lender revenue. The problem is borrower cash flow.

Interest coverage ratio explained - the core metric:

  • Coverage ratio = EBITDA / interest expense.
  • If the ratio falls below 1 the business generates less operating cash than it needs to pay interest.
  • Loans written during the zero-rate years (2018-2021) had aggressive loan-to-value and loan-to-EBITDA assumptions. Many of those vintages mature now and require refinancing in a much higher rate environment.

The consequence is simple math - a business that cleared interest at 4 percent may not survive paying at 10 percent. Refinancing becomes impossible for many.

4.PIK and PIKV - how funds mask true stress

When borrowers cannot make cash interest payments, lenders have options. One common accounting tool is Payment-In-Kind (PIK) - unpaid interest is capitalized into the loan principal instead of paid in cash. There are two contexts:

  • Planned PIK - written into the original contract for deliberate cash conservation during growth or capex phases.
  • PIKV amendment - retroactive change to allow accrued interest to roll into principal while avoiding a formal default. This hides real cash stress.

PIKV amendments keep loans labeled as "performing" on fund statements while eliminating cash flow to the fund. That reduces transparency for investors and increases systemic fragility.

5.NAV debt - the silo collapses

SPV silos protected individual deals. NAV - net asset value - debt breaks that isolation. Instead of borrowing at the company level, funds borrow against the combined value of all portfolio assets at the fund level. Uses fall into three buckets:

  • Offensive - buy additional assets using portfolio collateral.
  • Defensive - provide rescue capital for a struggling portfolio company.
  • Liquidity - borrow expensive money to pay distributions to limited partners so DPI looks healthy.

NAV debt removes the quarantine. If a few companies deteriorate the lender can demand repayment or collateral adjustments at the fund level, forcing sales of otherwise healthy companies at fire-sale prices. The incentive problem is clear - managers may borrow to manufacture short-term cash metrics so they can raise the next fund and collect more fees.

6.The dual-sided liquidity squeeze - banks and retail at the same time

The squeeze is mechanical and simultaneous:

  1. Institutional side - banks provide back-leverage to funds using private loans as collateral. When banks mark those loans down - for example because AI threatens recurring revenue models for legacy SaaS companies - the fund’s credit lines tighten instantly.
  2. Retail side - about $220 billion sits in evergreen private credit vehicles that promise periodic liquidity. These funds are durable only when new inflows outpace redemptions. If retail investors pull cash faster than new money arrives the fund must source liquidity elsewhere - at the worst possible price.

When a bank tightens a credit line at the same time retail investors request redemptions, funds face a true liquidity treadmill. Several high-profile evergreen funds have gated withdrawals recently. That is classic liquidity mismatch risk - short-term promises funded with long-term, illiquid assets.

7.Why AI matters here

Banks model future cash flows to value collateral. Rapid shifts in technology - generative AI in particular - change those projected cash flows for software businesses. A bank that preemptively lowers its collateral valuation reduces the borrowing base for funds that used those loans as back-leverage.

That mark-to-risk action is not speculative theater. It has immediate mechanical consequences for fund liquidity.

8.Downstream: healthcare and the human cost

Private credit funded aggressive roll-ups in healthcare - physician groups, emergency staffing, nursing homes. Healthcare roll-ups frequently operate with the weakest coverage ratios in private credit, averaging roughly 1.1 times in recent data. That leaves almost no margin for rate shocks or regulatory change.

Illustrative case - Envision Healthcare:

  • Acquired with roughly $7 billion in debt.
  • Relied heavily on out-of-network billing to generate excess cash.
  • Regulatory change - No Surprises Act - removed that revenue channel, making the debt mathematically unsustainable and leading to bankruptcy.

When debt cannot be repaid you cannot repossess a doctor. The lever available to acquirers is labor economics: mandate higher patient volumes, cut clinician pay, replace physicians with lower-cost clinician extenders. Academic studies show higher patient costs and measurable increases in adverse outcomes after some private equity-backed healthcare acquisitions. That is how shadow banking mechanics translate into real-world patient impact.

9.What to watch next - indicators that matter

  • Interest coverage ratios at the portfolio company level - look for broad declines below 1.2.
  • Share of loans moving to PIK or amended to PIKV - rising levels are a red flag.
  • NAV debt outstanding and utilization rates for fund-level facilities.
  • Bank borrowings and back-leverage utilization - signs of banks marking down collateral.
  • Redemption pressure and gating at major evergreen funds - quarter-to-quarter flows.
  • Default rates in healthcare and other weak-credit sectors.

10.Practical steps - what investors and stakeholders can do

For institutional investors and high net worth individuals:

  • Audit fund terms - understand whether a vehicle is evergreen or a closed drawdown structure and the liquidity mismatch it creates.
  • Monitor DPI, NAV debt, and PIK metrics. These are leading indicators of stress.
  • Demand transparency on fund-level borrowings and covenant triggers.

For everyday stakeholders - patients, employees, and local communities:

  • Track ownership changes at local hospitals and physician groups. Ownership shifts often precede operational changes.
  • Know your rights under surprise-billing protections and how they affect provider networks and billing practices.
  • If you rely on a facility for critical care, watch for evidence of staffing cuts or increased turnover among clinicians.

11.Conclusion - connect the plumbing to the headlines

Private credit is the financial plumbing for a large portion of the modern economy. It was designed to operate outside the regulated banking system and deliver higher yields. That architecture worked in a low-rate environment but it is brittle when interest rates move and collateral valuations shift rapidly.

The failure modes are predictable: borrowers with weak coverage ratios cannot absorb floating-rate spikes; PIKV amendments and NAV loans mask stress while amplifying contagion; bank markdowns and retail redemptions can create simultaneous funding squeezes. When that happens the effects are not abstract - they show up in higher medical bills, staffing stresses at emergency rooms, and potential losses for pension funds and retail investors.

Sources and further reading

  • ECGI - European Corporate Governance Institute: https://www.ecgi.org
  • Apollo Global Management - Research and Academy materials: https://www.apollo.com
  • Reporting on private equity and healthcare - ProPublica: https://www.propublica.org
  • Envision Healthcare coverage and bankruptcy details - The New York Times: https://www.nytimes.com
  • Industry discussions on NAV loans and evergreen structures - investment manager white papers (example providers: Blackstone, Blue Owl)
  • Federal Reserve data and bank supervisory statements: https://www.federalreserve.gov

IMPORTANT DISCLAIMER: This document is provided for informational and educational purposes only. It does not constitute investment, legal, tax, or other professional advice, and nothing herein should be construed as a recommendation, offer, or solicitation to buy or sell any security. Information is from sources believed reliable but not guaranteed; certain figures are estimates that may prove incorrect. Past performance is not indicative of future results, and all investments involve risk, including possible loss of principal. Conduct your own due diligence and consult a licensed professional before investing. Carlos Artiles accepts no liability for any loss arising from use of this material.

CARLOS ARTILES · Strategy. Growth. Life by Design.Informational use only — not investment advice